# Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

> clinical trial · VERIFIED · 2026-06-10

Status: COMPLETED · Sponsor: Central Hospital, Nancy, France · Condition: Hepatocellular Carcinoma

- Company: Central Hospital, Nancy, France
- Sector: diagnostics
- Primary source: https://clinicaltrials.gov/study/NCT03311152

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.